Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis Syndromes: Recommendations From the US Multi-Society Task Force on Colorectal Cancer Post author:GIBoardReview.com Post published:May 17, 2022 Post category:Society Guidelines You Might Also Like AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review June 1, 2019 AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review May 1, 2020 AASLD Practice Guidance on Acute-on-chronic Liver Failure and the Management of Critically Ill Patients with Cirrhosis September 27, 2024
AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review June 1, 2019
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review May 1, 2020
AASLD Practice Guidance on Acute-on-chronic Liver Failure and the Management of Critically Ill Patients with Cirrhosis September 27, 2024